ALLMedicine™ Injecting Drug Use Center

Mar 17th, 2023 - Background: Globally, street-involved children and youth (SICY) who work and live on/of the streets are at higher risk of increased psychoactive substances and injecting drug use. Objectives: The present study aimed to identify the prevalence, dis...

Mar 12th, 2023 - We analysed hepatitis B surface antigen (HBsAg) screening and seropositivity within a network of 419 general practices representative of all regions of England. Information was extracted using pseudonymised registration data. Predictors of HBsAg s...

Feb 13th, 2023 - There has been a substantial global increase in cocaine use and associated harms. The current study aimed to: 1. Determine the case characteristics and circumstances of death of cocaine-related suicide in Australia 2000-2021; and 2. Determine the ...

Feb 10th, 2023 - Rationale: As highly effective therapy against hepatitis C virus (HCV) infection is available with rapid uptake, there is newfound optimism for HCV elimination. Nevertheless, HCV reinfections cause great concern in at risk populations, including m...

Feb 7th, 2023 - Opioid use disorder is a serious public health problem in Nepal. People who use opioids often experience psychological distress and poor quality of life. Opioid agonist Treatment (OAT) is central in managing opioid dependence. This study aimed to ...

Feb 10th, 2023 - Rationale: As highly effective therapy against hepatitis C virus (HCV) infection is available with rapid uptake, there is newfound optimism for HCV elimination. Nevertheless, HCV reinfections cause great concern in at risk populations, including m...

Jan 27th, 2023 - Hepatitis C is a blood-borne virus (HCV) that can seriously damage the liver and is spread mainly through blood-to-blood contact with an infected person. The "serious and significant public health risk" posed by HCV was recognised during a member'...

Jan 17th, 2023 - The TEMPO study will compare dried blood spot testing and point-of-care HCV RNA testing to standard of care as strategies to enhance HCV treatment uptake among people with HCV and recent injecting drug use attending NSP services. Peer support to e...

Aug 18th, 2022 - The QuickStart Study will explore models of point-of-care HCV testing and a same-day test and treat model to determine the impact of these models on HCV treatment initiation and cure. The study is a cluster cross-over randomised controlled trial. ...

May 25th, 2022 - EZ-C's purpose is to determine the effectiveness of patient navigation services during treatment of hepatitis C compared to usual care among opioid substitution therapy (OST) and active injecting drug use (IDU) individuals. To recruit OST and acti...

Jan 22nd, 2020 - Hepatitis C virus (HCV) is known to be a common sexually transmitted infection (STI) among HIV-positive men who have sex with men (MSM). To examine this relationship in HIV-negative MSM, researchers in the Amsterdam PrEP Project team in the HIV Tr.

Jul 3rd, 2018 - SAN DIEGO – The transition from noninjecting to injecting drug use can be a reversible process, results from a long-term study suggest. “There’s a common stereotype in popular culture and in academic research that once people start injecting drugs.

Jul 3rd, 2018 - SAN DIEGO – The transition from noninjecting to injecting drug use can be a reversible process, results from a long-term study suggest. “There’s a common stereotype in popular culture and in academic research that once people start injecting drugs.

Feb 3rd, 2015 - Most individuals who use injection drugs inject their drugs intravenously, but subcutaneous injection (ie, "skin-popping") is also common, and intramuscular injection may occur intentionally or when the individual misses the vein or the subcutaneo...

Jun 12th, 2013 - Preexposure prophylaxis (PrEP) with tenofovir disoproxil fumarate nearly halved (48.9%) HIV infection rates in injection drug users, according to a randomized, double-blind, placebo-controlled, phase 3 trial of 2413 participants in Thailand. Kachi...